• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Oflo-Avenir
    / BioAvenir Ltd.


    Active Ingredient
    Ofloxacin 3 mg/ml

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Solution

    10 ml

    partial basket chart

    Related information


    Dosage

    One or two drops, three or four times daily in the affected eye(s).
    Treatment should not be continued for more than ten days.
    Please refer to the license holder for further details


    Indications

    Topical treatment of external eye infections such as conjunctivitis


    Contra-Indications

    * Hypersensitivity to active ingredient or any other ingredients.
    * Children and adolescents
    * Pregnant or breast-feeding


    Special Precautions

    * Defect or ulceration of the surface of the eye
    * Epilepsy or other brain or nerve disorders.
    * Liver or kidney problems
    * Severe dehydration
    * Heart conditions
    * Contact lenses should not be used.
    Please refer to the license holder for further details.


    Side Effects

    Common: Eye irritation, ocular discomfort
    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Manufacturer
    Farmigea
    Licence holder
    CLOSE